Beacon Chemical Co. Inc. – Trademark Portfolio

Entity Type: 98

Beacon Chemical Co. Inc. holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 8 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include MAGNA-TAC and FABRI- TAC. The owner is based in New York, NY.

New York, NY

9 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Beacon Chemical Co. Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (8 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Beacon Chemical Co. Inc. have?

Beacon Chemical Co. Inc. has 9 U.S. trademarks filed with the USPTO. Of these, 2 registered, 7 cancelled.

What trademark classes does Beacon Chemical Co. Inc. file in?

Beacon Chemical Co. Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are Beacon Chemical Co. Inc.'s most well-known trademarks?

Beacon Chemical Co. Inc.'s registered trademark portfolio includes well-known marks such as MAGNA-TAC and FABRI- TAC. These are among 2 currently registered trademarks in the portfolio.

What is Beacon Chemical Co. Inc.'s trademark registration success rate?

Beacon Chemical Co. Inc. has a 22% trademark registration rate, with 2 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.